Kampala, Uganda | URN | The Ministry of Health revealed Friday that demand for Lenacapavir, an HIV prevention injection launched in April, currently surpasses available doses, with more men demanding the twice-yearly drug. Speaking at a meeting attended by HIV advocates, researchers and policymakers, Dr Herbert Kadama who coordinates …
Read More »
Kampala, Uganda | URN | The Ministry of Health will, on Friday, roll out the countrywide use of Lenacapavir injection at Lira Regional Referral Hospital. In July last year, the World Health Organization (WHO) released guidelines recommending the use of injectable lenacapvir(LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) …
Read More »
Kampala, Uganda | THE INDEPENDENT | HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for Pre-Exposure Prophylaxis (PrEP) under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a new modelling study warns. The pre-print study, led by Dr. Jack Stone, Associate Professor …
Read More »
Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) for the prevention of HIV as pre-exposure prophylaxis (PrEP). LEN, developed by Gilead Sciences, is a twice-yearly injectable PrEP option that showed nearly complete protection against HIV in the landmark PURPOSE 1 and 2 …
Read More »
SPECIAL REPORT | THE INDEPENDENT | Philanthropist Bill Gates, the founder and co-chair of the Bill and Melinda Gates Foundation says more lives can be saved from HIV if modern HIV prevention tools can be spread out. The Bill and Melinda Gates Foundation has been one of the biggest funder to …
Read More »
Kampala, Uganda | THE INDEPENDENT | A new HIV prevention study has found that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected women from contracting HIV. Findings of the the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda was released …
Read More »
Virus still a burden among young people Kampala, Uganda | PATRICIA AKANKWATSA | Uganda Network of AIDS Services Organisation (UNASO) wants the fight against HIV/AIDS in Uganda to focus on encourage health-seeking behavior as the disease continues to spread; especially among young people. While presenting the National HIV/Aids Report, Dr …
Read More »
Kampala, Uganda | THE INDEPENDENT | The World Health Organization-WHO on Thursday released new guidelines giving countries a green light to use long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. The guidelines that were released ahead of the annual International AIDS Conference will support countries as they plan for …
Read More »
Study shows why it matters to young African women Kampala, Uganda | RONALD MUSOKE | A new HIV prevention study has found that when young women have access to and experience with two biomedical prevention options, the Dapivirine Vaginal Ring (DVR) and Truvada, an oral pre-exposure prophylaxis (PrEP) drug, almost …
Read More »
Kampala, Uganda | THE INDEPENDENT | Researchers will in December enroll the first participants in a clinical trial in which they are testing the effectiveness of a new HIV drug, Lenacapavir in protecting people against the virus. This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
